Varian Medical Systems Announces Particle Therapy Scientific Advisory Board | Varian

{ "pageType": "news-article", "title": "Varian Medical Systems Announces Particle Therapy Scientific Advisory Board", "articleDate": "2016/03/07", "introText": "", "category": "Corporate and Financial Releases" }

Varian Medical Systems Announces Particle Therapy Scientific Advisory Board

PALO ALTO, Calif., March 7, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the formation, and first meeting, of its Particle Therapy Advisory Board. Comprised of a diverse group of radiation oncologists and physicists from many prestigious institutions from around the world, and offering over 450 years of collective experience in the field, the 20-member Advisory Board will provide valuable clinical insights on particle therapy and feedback to Varian on product and program development.

"This Advisory Board provides Varian a unique opportunity to have regular in-depth discussions with some of the leading radiation oncologists and physicists to address important topics such as adaptive proton therapy and the future of imaging, which are critical to the continued development of this cancer-fighting technology," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division. 

Comments from the Advisory Board

"I've been working with Varian's ProBeam system since 2014 and because of their scanning technology I have been able to treat more complex-shaped and larger tumors than I could previously. This advisory board is further evidence that Varian is focused on the future of particle therapy and they are collaborating with a strong team of radiation oncologists and physicists to advise them as they continue to bring technical innovation to proton therapy," said Dr. Carl Rossi, medical director, Scripps Proton Therapy Center.

"I applaud Varian for bringing together a diverse group of thought leaders to discuss how to advance proton therapy," said Dr. Steven Frank, medical director, MD Anderson Proton Therapy Center. "I look forward to working in partnership with my fellow advisory board members and the Varian team on increasing patient access to this valuable cancer fighting technology."

"Proton therapy will be an important part of our radiation oncology offerings at Memorial Sloan Kettering," said Dr. Simon Powell, chair of the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. "Participating in Varian's Particle Therapy Advisory Board provides the opportunity to partner with colleagues from around the world to discuss advancements to proton therapy, such as the implications of new radiobiology research."

Proton therapy makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The method can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients the risk of developing a new, radiation-induced cancer later in life can be reduced.

Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Maryland Proton Treatment Center in Baltimore, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland. Varian also has contracts for system installations at 13 other sites around the world.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, cables and connectors as well as image processing software and workstations for use in medical and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 7,400 people who are located at manufacturing sites in North America, Europe, and China and sales and support offices around the world.  For more information, visit or follow us on Twitter.

Press Contact

Mark Plungy
Varian Medical Systems
+1 (650) 424-5630


SOURCE Varian Medical Systems